Pro-inflammatory cytokine expression in LPS-stimulated macrophages

Pro-inflammatory cytokine expression in LPS-stimulated macrophages is a complex biological process rather than a single molecular target. This process is initiated when Lipopolysaccharide (LPS), a major component of Gram-negative bacterial cell walls, binds to the Toll-like receptor 4 (TLR4)/MD-2 complex on the macrophage surface (Beutler et al., 2000, Science). This binding event triggers a robust intracellular signaling cascade involving the MyD88-dependent and TRIF-dependent pathways, which activate NF-κB and Mitogen-Activated Protein Kinases (MAPKs) such as p38, JNK, and ERK (Guha & Mackman, 2001, Free Radical Biology and Medicine). The activation of these pathways leads to the transcription and secretion of potent pro-inflammatory mediators, including TNF-α, IL-1β, and IL-6, which are essential for the innate immune response (Dinarello, 2000, Chest). In drug discovery, this system is widely utilized as a phenotypic assay to screen for anti-inflammatory compounds that can modulate or inhibit excessive immune activation. While necessary for host defense, chronic or systemic over-activation of this process is a primary driver of pathological conditions such as septic shock, rheumatoid arthritis, and inflammatory bowel disease (O'Neill et al., 2013, Nature Reviews Immunology).

Other names

LPS-induced cytokine productionMacrophage inflammatory responseTLR4-mediated cytokine expressionEndotoxin-induced macrophage activation

Inhibition of the TLR4 signaling cascade, suppression of NF-κB nuclear translocation, or blockade of MAP kinase phosphorylation to prevent the transcriptional upregulation and secretion of inflammatory mediators (O'Neill et al., 2013).